| Exploiting metabolic glycoengineering to advance healthcare C Agatemor, MJ Buettner, R Ariss, K Muthiah, CT Saeui, KJ Yarema Nature Reviews Chemistry 3 (10), 605-620, 2019 | 118 | 2019 |
| Improving immunotherapy through glycodesign MJ Buettner, SR Shah, CT Saeui, R Ariss, KJ Yarema Frontiers in immunology 9, 2485, 2018 | 67 | 2018 |
| Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells MP Mathew, E Tan, CT Saeui, P Bovonratwet, S Sklar, R Bhattacharya, ... Oncotarget 7 (41), 66491, 2016 | 38 | 2016 |
| Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib MP Mathew, E Tan, CT Saeui, P Bovonratwet, L Liu, R Bhattacharya, ... Bioorganic & Medicinal Chemistry Letters 25 (6), 1223-1227, 2015 | 37 | 2015 |
| Cell surface and membrane engineering: emerging technologies and applications CT Saeui, MP Mathew, L Liu, E Urias, KJ Yarema Journal of functional biomaterials 6 (2), 454-485, 2015 | 36 | 2015 |
| Biodynamic performance of hyaluronic acid versus synovial fluid of the knee in osteoarthritis M Corvelli, B Che, C Saeui, A Singh, J Elisseeff Methods 84, 90-98, 2015 | 32 | 2015 |
| Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells Y Tian, RT Almaraz, CH Choi, QK Li, C Saeui, D Li, P Shah, ... Clinical proteomics 12, 1-13, 2015 | 31 | 2015 |
| Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example HA Badr, DMM AlSadek, ME El-Houseini, CT Saeui, MP Mathew, ... Biomaterials 116, 158-173, 2017 | 30 | 2017 |
| Combining butyrated ManNAc with glycoengineered CHO cells improves EPO glycan quality and production Q Wang, CY Chung, W Yang, G Yang, S Chough, Y Chen, B Yin, ... Biotechnology Journal 14 (4), 1800186, 2019 | 23 | 2019 |
| Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands K Worm, QJ Zhou, CT Saeui, RC Green, JA Cassel, GJ Stabley, ... Bioorganic & medicinal chemistry letters 18 (9), 2830-2835, 2008 | 22 | 2008 |
| Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications CT Saeui, E Urias, L Liu, MP Mathew, KJ Yarema Glycoconjugate journal 32, 425-441, 2015 | 21 | 2015 |
| Improving the pharmacodynamics and in vivo activity of ENPP1‐Fc through protein and glycosylation engineering PR Stabach, K Zimmerman, A Adame, D Kavanagh, CT Saeui, ... Clinical and translational science 14 (1), 362-372, 2021 | 19 | 2021 |
| Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes CT Saeui, AV Nairn, M Galizzi, C Douville, P Gowda, M Park, ... PLoS One 13 (5), e0195812, 2018 | 19 | 2018 |
| Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists GH Chu, CT Saeui, K Worm, DG Weaver, AJ Goodman, RL Broadrup, ... Bioorganic & medicinal chemistry letters 19 (20), 5931-5935, 2009 | 19 | 2009 |
| Determination of absolute expression profiles using multiplexed miRNA analysis Y Song, D Kilburn, JH Song, Y Cheng, CT Saeui, DG Cheung, CM Croce, ... PLoS One 12 (7), e0180988, 2017 | 18 | 2017 |
| Novel sulfamoyl benzamides as selective CB2 agonists with improved in vitro metabolic stability I Sellitto, B Le Bourdonnec, K Worm, A Goodman, MA Savolainen, ... Bioorganic & medicinal chemistry letters 20 (1), 387-391, 2010 | 18 | 2010 |
| Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists K Worm, DG Weaver, RC Green, CT Saeui, DMS Dulay, WM Barker, ... Bioorganic & medicinal chemistry letters 19 (17), 5004-5008, 2009 | 14 | 2009 |
| Pharmacological, physiochemical, and drug-relevant biological properties of short chain fatty acid hexosamine analogues used in metabolic glycoengineering CT Saeui, L Liu, E Urias, J Morrissette-McAlmon, R Bhattacharya, ... Molecular pharmaceutics 15 (3), 705-720, 2017 | 13 | 2017 |
| Glycoengineering of Esterase Activity through Metabolic Flux‐Based Modulation of Sialic Acid MP Mathew, E Tan, JW Labonte, S Shah, CT Saeui, L Liu, R Bhattacharya, ... ChemBioChem 18 (13), 1204-1215, 2017 | 12 | 2017 |
| Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified N-Acetylmannosamine (ManNAc) Analogs J Du, C Agatemor, CT Saeui, R Bhattacharya, X Jia, KJ Yarema Cells 10 (2), 377, 2021 | 10 | 2021 |
